Long-term outcome of stage I seminoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 30, Issue 2, 2007, Pages 205-210

  Yang, Gary Y ^a   Li, Baoqing ^a   Wagner, Timothy D ^a   Donohue, Kathleen A ^b   Flaherty, Leayn ^a   Kuettel, Michael R ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Local control; Outcomes; Pure seminoma; Radiation; Second malignancy; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER RISK; CANCER STAGING; FOLLOW UP; HUMAN; HUMAN TISSUE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; ORCHIECTOMY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT ASSESSMENT; POSTMARKETING SURVEILLANCE; RECURRENCE RISK; RETROSPECTIVE STUDY; SEMINOMA; STATISTICAL SIGNIFICANCE;

ADULT; AGED; DATABASES, FACTUAL; DISEASE-FREE SURVIVAL; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; RECURRENCE; RETROSPECTIVE STUDIES; SEMINOMA; SURVIVAL ANALYSIS; TESTICULAR NEOPLASMS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34147180049     PISSN: 02773732     EISSN: 1537453X     Source Type: Journal    
DOI: 10.1097/01.coc.0000255613.72254.31     Document Type: Article

References (21)

1. Steele GS, Richie JP, Stewart AK, et al. The national cancer data base report on pattern of care for testicular carcinoma, 1985-1996. Cancer. 1999;86:2171-2183.
2. Fossa SD, Aass N, Kaalhaus O. Radiotherapy for testicular seminoma stage I: treatment results and long-term post-irradiation morbidity in 365 patients. Int J Radiat Oncol Biol Phys. 1989;16:383-388.
3. Jones RH, Vasey PA. Part I: testicular cancer-management of early disease. Lancet Oncol. 2003;4:730-736.
4. Horwich A. Radiotherapy in stage I seminoma of testis. J Clin Oncol. 2004;22:585-588.
5. Fossa SD, Horwich A, Russell JM, et al. Optimal planning target volume for stage I testicular seminoma: a Medical Research Council randomized trial. Medical Research Council Testicular Tumor Working Group. J Clin Oncol. 1999;17:1146-1154.
6. Warde P, Specht L, Horwich A, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002;20:4448-4452.
7. Travis L, Curtis R, Storm H, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst. 1997;89:1429-1439.
8. Schemper M, Smith TL. A note on quantifying follow-up in studies of failure time. Controlled Clin Trials. 1996;17:343-346.
9. Horwich A, Alsanjari N, A'Hern R, et al. Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer. 1992;65:775-778.
10. Holzbeierlein JM, Sogani PC, Sheinfeld J. Histology and clinical outcomes in patients with bilateral testicular germ cell tumors: the Memorial Sloan Kettering Cancer Center experience 1950-2001. J Urol. 2003;169:2122-2125.
11. Theodore CH, Terrier-Lacombe MJ, Laplanche A, et al. Bilateral germcell tumors: 22-year experience at the Institute Gustave Roussy. Br J Cancer. 2004;90:55-59.
12. Warde P, Gospodarowicz MK, Banerjee D, et al. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. J Urol. 2002;157:1705-1709.
13. Francis R, Bower M, Brunstrom G, et al. Surveillance for stage I testicular germ cell tumors: results and cost benefit analysis of management options. Eur J Cancer. 2000;36:1925-1932.
14. Bokemeyer C, Schmool H. Treatment of testicular cancer and the development of secondary malignancies. J Clin Oncol. 1995;13:283-292.
15. Ruther U, Dieckmann KP, Bussar-Maatz R, et al. Second malignancy following pure seminoma. Oncology. 2000;58:75- 82.
16. Cahan WG, Woodard HQ, Higinbotham NL, et al. Sarcoma arising in irradiated bone: report of eleven cases. Cancer. 1948;1:3-29.
17. Choo R, Sandler H, Warde P, et al. Survey of radiation oncologists: practice pattern of the management of stage I seminoma of testis in Canada and a selected group in the United States. Can J Urol. 2002;9:1479-1485.
18. Warde P, Gospodarowicz M, Panzarella T, et al. Surveillance is an appropriate management strategy in patients with Stage I seminoma. Int J Radiat Oncol Biol Phys. 2002;54:61.
19. Daugaard G, Petersen PM, Rorth M. Surveillance in stage I testicular cancer. APMIS. 2003;111:76-83.
20. Santoni R, Babera F, Bertoni F, et al. Stage I seminoma of the testis: a bi-institutional retrospective analysis of patients treated with radiation therapy only. Br J Urol Int. 2003;92:47-52.
21. Bayens YC, Helle PA, Van PW, et al. Orchidectomy followed by radiotherapy in 176 stage I and II testicular seminoma patients: benefits of a 10-year follow-up study. Radiother Oncol. 1992;25:97-102.